Literature DB >> 25399386

Clinical features and radiological findings in large vessel vasculitis: are Takayasu arteritis and giant cell arteritis 2 different diseases or a single entity?

Shunsuke Furuta1, Claire Cousins2, Afzal Chaudhry2, David Jayne2.   

Abstract

OBJECTIVE: Takayasu arteritis (TAK) and giant cell arteritis (GCA) are 2 major variants of large vessel vasculitis (LVV). The frequent involvement of large vessels in GCA has raised the possibility that TAK and GCA should be regarded as 1 disease. By detailed phenotyping of a single-center cohort, we aimed to define the differences between TAK and GCA.
METHODS: Forty-five patients (23 TAK, 22 GCA) were identified. Baseline characteristics, clinical symptoms, laboratory data, enhanced computed tomography/magnetic resonance imaging, treatments, and clinical courses were retrospectively assessed with descriptive statistics. In addition, latent class analysis of the 45 patients was performed to explore phenotypic differences.
RESULTS: Patients with GCA had more frequent headache (p < 0.01), higher C-reactive protein levels (p = 0.01), and higher erythrocyte sedimentation rates (p = 0.03) than did patients with TAK at diagnosis. With the exception of subdiaphragmatic lesions, the distributions of vessel lesions were not different between TAK and GCA. However, focusing on subclavian and carotid arteries, long tapered-type stenotic lesions were more frequent in GCA than in TAK (p < 0.01). The proportion of patients without relapse was higher in GCA (60%) than in TAK (22%, p = 0.01). Latent class analysis also divided patients with LVV into 2 separate groups consistent with TAK and GCA.
CONCLUSION: The differences observed in clinical symptoms, inflammatory markers, radiological findings, and clinical courses suggested that TAK and GCA were 2 different diseases. Latent class analysis supported these results. The shape of stenotic lesions in the subclavian and carotid arteries is a useful discriminator between TAK and GCA.

Entities:  

Keywords:  GIANT CELL ARTERITIS; IMAGING; LATENT CLASS ANALYSIS; PHENOTYPE; PROGNOSIS; TAKAYASU ARTERITIS

Mesh:

Year:  2014        PMID: 25399386     DOI: 10.3899/jrheum.140562

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  10 in total

Review 1.  Gastrointestinal aspects of vasculitides.

Authors:  Medha Soowamber; Adam V Weizman; Christian Pagnoux
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-11-23       Impact factor: 46.802

Review 2.  Imaging in Giant Cell Arteritis.

Authors:  Asad Khan; Bhaskar Dasgupta
Journal:  Curr Rheumatol Rep       Date:  2015-08       Impact factor: 4.592

Review 3.  Large-vessel vasculitis.

Authors:  Dan Pugh; Maira Karabayas; Neil Basu; Maria C Cid; Ruchika Goel; Carl S Goodyear; Peter C Grayson; Stephen P McAdoo; Justin C Mason; Catherine Owen; Cornelia M Weyand; Taryn Youngstein; Neeraj Dhaun
Journal:  Nat Rev Dis Primers       Date:  2022-01-06       Impact factor: 65.038

4.  Development of a Core Set of Outcome Measures for Large-vessel Vasculitis: Report from OMERACT 2016.

Authors:  Antoine G Sreih; Fatma Alibaz-Oner; Tanaz A Kermani; Sibel Z Aydin; Peter F Cronholm; Trocon Davis; Ebony Easley; Ahmet Gul; Alfred Mahr; Carol A McAlear; Nataliya Milman; Joanna C Robson; Gunnar Tomasson; Haner Direskeneli; Peter A Merkel
Journal:  J Rheumatol       Date:  2017-09-01       Impact factor: 4.666

Review 5.  Diagnosis and differential diagnosis of large-vessel vasculitides.

Authors:  Gokhan Keser; Kenan Aksu
Journal:  Rheumatol Int       Date:  2018-09-17       Impact factor: 2.631

6.  The Role of Vascular Imaging to Advance Clinical Care and Research in Large-Vessel Vasculitis.

Authors:  Kaitlin A Quinn; Peter C Grayson
Journal:  Curr Treatm Opt Rheumatol       Date:  2019-02-09

7.  Patterns of Arterial Disease in Takayasu Arteritis and Giant Cell Arteritis.

Authors:  K Bates Gribbons; Cristina Ponte; Simon Carette; Anthea Craven; David Cuthbertson; Gary S Hoffman; Nader A Khalidi; Curry L Koening; Carol A Langford; Kathleen Maksimowicz-McKinnon; Carol A McAlear; Paul A Monach; Larry W Moreland; Christian Pagnoux; Kaitlin A Quinn; Joanna C Robson; Philip Seo; Antoine G Sreih; Ravi Suppiah; Kenneth J Warrington; Steven R Ytterberg; Raashid Luqmani; Richard Watts; Peter A Merkel; Peter C Grayson
Journal:  Arthritis Care Res (Hoboken)       Date:  2020-11       Impact factor: 5.178

8.  Serum levels of fibroblast growth factor-2 distinguish Takayasu arteritis from giant cell arteritis independent of age at diagnosis.

Authors:  Shoichi Fukui; Ayako Kuwahara-Takaki; Nobuyuki Ono; Shuntaro Sato; Tomohiro Koga; Shin-Ya Kawashiri; Nozomi Iwanaga; Naoki Iwamoto; Kunihiro Ichinose; Mami Tamai; Hideki Nakamura; Tomoki Origuchi; Kiyoshi Migita; Yojiro Arinobu; Hiroaki Niiro; Yoshifumi Tada; Koichi Akashi; Takahiro Maeda; Atsushi Kawakami
Journal:  Sci Rep       Date:  2019-01-24       Impact factor: 4.379

9.  Significant association between clinical characteristics and changes in peripheral immuno-phenotype in large vessel vasculitis.

Authors:  Kotaro Matsumoto; Katsuya Suzuki; Keiko Yoshimoto; Noriyasu Seki; Hideto Tsujimoto; Kenji Chiba; Tsutomu Takeuchi
Journal:  Arthritis Res Ther       Date:  2019-12-30       Impact factor: 5.156

Review 10.  Imaging for Diagnosis, Monitoring, and Outcome Prediction of Large Vessel Vasculitides.

Authors:  Valentin Sebastian Schäfer; Lei Jin; Wolfgang Andreas Schmidt
Journal:  Curr Rheumatol Rep       Date:  2020-09-21       Impact factor: 4.592

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.